CYTOSORBENTS CORP(NASDAQ:CTSO) stock News

CTSO Latest News, Press Relases and Analysis

All

Press Releases

4 days ago - By: Chartmill - Mentions: LZB AHL NBY JHX ...

Wednesday's pre-market session: top gainers and losers

17 days ago - By: Chartmill

CytoSorbents Corp (NASDAQ:CTSO) Reports Mixed Q2 2025 Earnings with Revenue Beat and Narrower Loss

4 days ago - By: Benzinga - Mentions: NBY CLDX ALC THAR ...

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

4 days ago - By: Benzinga - Mentions: PPCB RCKT CNF NBY ...

Why Rocket Pharmaceuticals Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket

4 days ago - By: CytoSorbents Corporation

CytoSorbents Updates U.S. FDA Regulatory Status of DrugSorb-ATR

17 days ago - By: Cytosorbents Corp

CytoSorbents Reports Second Quarter 2025 Financial Results and Provides Business Update

a month ago - By: Cytosorbents Corp

CytoSorbents to Report Second Quarter 2025 Financial Results and Recent Business Highlights

2 months ago - By: Cytosorbents Corp

CytoSorbents Provides U.S. FDA and Health Canada Regulatory Update for DrugSorb-ATR

2 months ago - By: Cytosorbents Corp

CytoSorbents Files Appeal with U.S. FDA for Supervisory Review of its De Novo Request for DrugSorb™-ATR

3 months ago - By: Cytosorbents Corp

CytoSorbents to Participate at the Jefferies Global Healthcare Conference

3 months ago - By: Cytosorbents Corp

CytoSorbents Therapy Significantly Reduces Bleeding in Urgent CABG Patients on Ticagrelor in New Data Presented at EuroPCR 2025

3 months ago - By: Cytosorbents Corp

CytoSorbents Reports First Quarter 2025 Financial Results and Provides Business Update

4 months ago - By: Cytosorbents Corp

CytoSorbents Provides Regulatory Update for DrugSorb-ATR

4 months ago - By: Cytosorbents Corp

CytoSorbents to Report First Quarter 2025 Financial Results and Recent Business Highlights

4 months ago - By: CytoSorbents Corporation

CytoSorbents Receives Approximately $1.7 Million from the New Jersey Business Tax Certificate Transfer Program

4 months ago - By: Cytosorbents Corp

CytoSorbents Appoints Melanie Grossman, CPA as Vice President and Corporate Controller

4 months ago - By: Cytosorbents Corp

CytoSorbents Appoints Thomas Shannon as Vice President of Marketing for North America

5 months ago - By: Cytosorbents Corp

CytoSorbents Extends Expiration Date of Outstanding Series B Right Warrants

5 months ago - By: Cytosorbents Corp

CytoSorbents Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

5 months ago - By: Cytosorbents Corp

CytoSorbents Reschedules Earnings Release to March 31, 2025 to Allow Additional Time to Complete Annual Audit

6 months ago - By: CytoSorbents

CytoSorbents Postpones Earnings Release to Allow More Time to Complete Annual Audit Following the Passing of Corporate Controller

6 months ago - By: CytoSorbents

CytoSorbents Postpones Earnings Release to Allow More Time to Complete Annual Audit Following the Passing of Corporate Controller

6 months ago - By: CytoSorbents

CytoSorbents to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

6 months ago - By: CytoSorbents

CYTOSORBENTS CORP (CTSO) Stock News

CTSO Latest News, Press Relases and Analysis

Wednesday's pre-market session: top gainers and losers

CytoSorbents Corp (NASDAQ:CTSO) Reports Mixed Q2 2025 Earnings with Revenue Beat and Narrower Loss

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Why Rocket Pharmaceuticals Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket

CytoSorbents Updates U.S. FDA Regulatory Status of DrugSorb-ATR

CytoSorbents Reports Second Quarter 2025 Financial Results and Provides Business Update

CytoSorbents to Report Second Quarter 2025 Financial Results and Recent Business Highlights

CytoSorbents Provides U.S. FDA and Health Canada Regulatory Update for DrugSorb-ATR

CytoSorbents Files Appeal with U.S. FDA for Supervisory Review of its De Novo Request for DrugSorb™-ATR

CytoSorbents to Participate at the Jefferies Global Healthcare Conference

CytoSorbents Therapy Significantly Reduces Bleeding in Urgent CABG Patients on Ticagrelor in New Data Presented at EuroPCR 2025

CytoSorbents Reports First Quarter 2025 Financial Results and Provides Business Update

CytoSorbents Provides Regulatory Update for DrugSorb-ATR

CytoSorbents to Report First Quarter 2025 Financial Results and Recent Business Highlights

CytoSorbents Receives Approximately $1.7 Million from the New Jersey Business Tax Certificate Transfer Program

CytoSorbents Appoints Melanie Grossman, CPA as Vice President and Corporate Controller

CytoSorbents Appoints Thomas Shannon as Vice President of Marketing for North America

CytoSorbents Extends Expiration Date of Outstanding Series B Right Warrants

CytoSorbents Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

CytoSorbents Reschedules Earnings Release to March 31, 2025 to Allow Additional Time to Complete Annual Audit

CytoSorbents Postpones Earnings Release to Allow More Time to Complete Annual Audit Following the Passing of Corporate Controller

CytoSorbents Postpones Earnings Release to Allow More Time to Complete Annual Audit Following the Passing of Corporate Controller

CytoSorbents to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

CytoSorbents Further Strengthens Balance Sheet with Exercise of Previously Announced Series A Right Warrants